Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass
Titel:
Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass
Auteur:
Hadji, P. Gamerdinger, D. Spieler, W. Kann, P. H. Loeffler, H. Articus, K. Möricke, R. Ziller, V.